Seegene Canada defines the “gold standard” in medical diagnostic technology. As the country’s largest provider of SARS-CoV-2 PCR tests, if you’ve had a COVID-19 test it’s likely that Seegene’s reagents were used to test your swab.
Who we are
Seegene Canada’s diagnostic products and platforms extend well beyond infectious disease and since before the COVID-19 pandemic began, Seegene Canada has been supporting Canada’s hospitals and major medical diagnostic labs with world-leading PCR tests, robotic liquid handlers, and proprietary priming chemistry.
On the front lines
Over the last several years, Seegene Canada has become one of the leading players in the rapidly expanding field of medical testing and molecular diagnostics.
Seegene’s automated liquid handlers (PCR testing machines) can be found in most of the major medical diagnostic labs across the country. Using Seegene technology, these labs are playing a significant role as Canada responds to the pandemic. Seegene’s cross-country web of automated diagnostic solutions also positions these labs for the diagnostic needs of the future.
The future of healthcare
Seegene Canada, by combining cutting-edge medical technology with emerging fields like artificial intelligence and quantum computing, will continue to build on its track record of collaboration and innovation. The world of truly personalized medicine and medical testing and diagnosis is around the corner, and Seegene Canada is on the front lines of these exciting developments.
“The future of healthcare will be driven by data. And as data and mobile medical diagnostics become more common and increasingly incorporated into our everyday lives, Seegene is positioned to become ‘the Google of physical information.’”
James Yantzi, President
Partnering with industry leaders
“Seegene was one of the first vendors able to provide reliable test kits and instrumentation to help labs like Mount Sinai’s offer molecular testing for COVID-19. They have played a major role in supporting labs across Ontario to meet the increasing demands for testing. Our lab now has seven of Seegene's testing machines and each one is capable of performing over 600 COVID-19 molecular tests per day.”
|Dr. Tony Mazzulli, Microbiologist-in-Chief
Mount Sinai’s Hospital